Robert Hammers | February 17, 2026 | Product Liability
Why Patients Are Filing Lawsuits Over Ozempic and Other GLP-1 Weight-Loss Drugs
GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro have become widely prescribed across the United States for managing diabetes and supporting weight loss. However, as their popularity has grown, scrutiny of their safety has increased. In recent years, patients have filed lawsuits alleging that manufacturers failed to adequately warn about certain severe side effects, including […]
